PEDIATRICS Vol. 107 No. 3 March 2001, pp. 598-601
| |
ABSTRACT |
|---|
|
|
|---|
The use of complementary and alternative medicine (CAM) to treat chronic illness or disability is increasing in the United States. This is especially evident among children with autism and related disorders. It may be challenging to the practicing pediatrician to distinguish among accepted biomedical treatments, unproven therapies, and alternative therapies. Moreover, there are no published guidelines regarding the use of CAM in the care of children with chronic illness or disability. To best serve the interests of children, it is important to maintain a scientific perspective, to provide balanced advice about therapeutic options, to guard against bias, and to establish and maintain a trusting relationship with families. This statement provides information and guidance for pediatricians when counseling families about CAM.
The use of complementary and alternative medicine (CAM) is
increasing in Western countries. Indeed, more than one third of the
adults in the United States have used CAM in recent
years.1,2 Pediatric use of CAM is especially likely among
children with chronic illness or disability. Up to 50% of children
with autism in the United States probably are using some form of
CAM.3 In many instances, the physician providing medical
care is unaware of the concurrent use of CAM. Increasingly,
pediatricians providing care for children with chronic illness or
disability are discussing CAM with families or are asked to prescribe
such treatments. Pediatricians' expertise in biomedicine may not
adequately prepare them for discussion of CAM.
CAM has been defined as "a broad domain of healing resources
that encompasses all health systems, modalities, and practices and
their accompanying theories and beliefs, other than those intrinsic to
the politically dominant health system of a particular society or
culture in a given historic period."4 An enormous array
of unconventional therapies may be used as alternative therapies
(instead of conventional treatments) or as complementary therapies (in
addition to conventional treatments) (see Fig
1).
![]()
STATEMENT OF THE PROBLEM
![]()
BACKGROUND INFORMATION AND DEFINITIONAL ISSUES

View larger version (35K):
[in a new window]
Fig. 1.
Biopsychosocial medicine and alternative medicine are broad systems of
health care that encompass theories, practices, and therapies.
Integrative medicine is a term loosely used to describe these systems
used in combination. Therapies (whether biomedical, complementary, or
alternative) are considered proven or unproven based on a hierarchy of
evidence.
Currently, courses on CAM approaches are offered in the majority of US medical schools.5 The US government established the Office of Alternative Medicine (now the National Center for Complementary and Alternative Medicine) in the National Institutes of Health to carry out scientific study of CAM.6
Biomedicine is based on laws of science and the rigorous applications of the scientific method. It may aptly be called scientific medicine or evidence-based medicine. Disease is explained by pathophysiologic processes, and treatments are designed to affect these processes. The term biopsychosocial medicine has long been used to describe a biomedical model that recognizes the importance of psychosocial factors.7 Biomedical treatments are based on accumulated evidence of effectiveness from peer-reviewed scientific research. There is a hierarchy of research evidence, at the top of which is the controlled clinical trial. Many accepted biomedical treatments lack evidence of effectiveness from controlled clinical trials (eg, the use of physical therapy in the care of the premature infant). Unproven therapies also may be based on pathophysiology and limited research, but they lack accepted standards of proven effectiveness (eg, the use of immunoglobulins in the treatment of autism).8 Alternative therapies are based on a variety of nonbiomedical beliefs and usually have not been subjected to clinical research. Most are supported by anecdotal evidence, but some alternative therapies have proven effectiveness. For example, preliminary studies of acupuncture in addiction treatment show positive results.9 In time, such proven therapies may come into wider use and lose their "alternative" status.
Biopsychosocial medicine and CAM have at least one thing in common: both recognize that the relationship between physician-healer and patient is integral to the success of treatments offered. This is part of the age-old "art" of medicine and is a basis of the placebo response.10 The emphasis of biomedicine on pathophysiology and on technical outcomes has reinforced the perception among some families that physicians undervalue their relationships with their patients. The failure of biomedicine to recognize and respond adequately to individual differences among patients is one reason families turn elsewhere and has contributed to the increasing use of CAM.
The distinctions among unproven therapies, CAM, and biomedicine may become especially blurred in the care of children with chronic illness or disability. Some conventional biomedical therapies lack proof of effectiveness, and some unproven and alternative therapies may in time prove effective. Also, some alternative therapies conceivably may have placebo effects, which confer additional therapeutic gain and enhanced quality of life. These factors may present significant challenges to the health care professional. Moreover, there are no published clinical guidelines regarding the use of CAM in the care of children with chronic illness or disability.11
| |
WHY PARENTS OF CHILDREN WITH CHRONIC ILLNESS OR DISABILITY CHOOSE CAM |
|---|
Parental questioning of a child's diagnosis, treatment, and prognosis reflects a normal process of adjustment to the permanence or chronicity of the condition and the desire to ensure the best possible outcome for their child. Many parents become frustrated with biomedical therapies because of complexity, discomfort, bewildering technology, or uncertainty of cure. Indeed, for some conditions, biomedicine has little or nothing to offer. Also, families may be frustrated because they have not been sufficiently involved in the development of a care plan. The media, condition-specific publications, and parent-to-parent contacts provide essential opportunities for families to learn about resources, including CAM. Furthermore, the Internet has dramatically increased exposure of families to sophisticated marketing, testimonials, and unproven claims. Some parents are attracted to simple explanations of causality, some by an approach perceived to be more "natural." Many try a succession of alternative therapies, believing that any approach that does no harm is worth a trial. For almost all, CAM approaches represent an attempt to gain a sense of control over their child's chronic illness or disability and to improve quality of life.
| |
BALANCING FAMILY-CENTERED CARE WITH THE ETHICAL RESPONSIBILITY OF THE PEDIATRICIAN |
|---|
The "medical home" concept emphasizes that care should be compassionate and family-centered. Mutual participation in decision making and informed consent are essential elements of respectful care.12 Decisions and plans should be made through a process of collaborative decision making in which the family receives complete and unbiased information needed to understand and make informed decisions. The quality of the relationship between the health care professional and patient with chronic illness has been shown clearly to affect outcomes.13 Honest and supportive relationships with health care professionals can help parents cope14 and promote the child's independence.15 Such relationships are strengthened when health care professionals understand the perspectives of the family, provide care with flexibility, and attempt to meet the family's needs and expectations. Clearly, it is optimal for children with chronic illness or disability to receive health care in a setting that is family-centered. At the same time, pediatricians have an ethical responsibility to guard the welfare of children by ensuring that any treatment they endorse is "in accordance with science and proven experience."16,17 Dilemmas may arise when families ask their pediatrician to endorse or to provide a therapy that is considered by the pediatrician not to be in the best interests of the child. There may be evidence of the possibility of direct harm, unknown risks, or concerns about indirect harm to the child. The pediatrician is in a position to balance a commitment to family-centered care with the ethical responsibility to guard the welfare of children.18,19
| |
SUMMARY/CONCLUSION |
|---|
|
|
|---|
The use of CAM approaches in the United States is increasing, especially among children with chronic illness or disability. Distinctions among unproven therapies, CAM, and biomedicine may become blurred, presenting special challenges to the pediatrician. To best serve the interests of children, it is important to provide balanced advice about therapeutic options, to guard against bias, and to establish and maintain a trusting relationship with families. Although the focus of this statement is chronic illness or disability, the recommendations that follow also may apply to the use of alternative medicine in other pediatric domains.
| |
RECOMMENDATIONS FOR PEDIATRICIANS WHO DISCUSS ALTERNATIVE, COMPLEMENTARY, AND UNPROVEN THERAPIES WITH FAMILIES |
|---|
Committee on Children With Disabilities, 2000-2001
Adrian D. Sandler, MD, Chairperson
Dana Brazdziunas, MD
W. Carl Cooley, MD
Lilliam González de Pijem, MD
David Hirsch, MD
Theodore A. Kastner, MD
Marian E. Kummer, MD
Richard D. Quint, MD, MPH
Elizabeth S. Ruppert, MD
Liaisons
Polly Arango
Family Voices
Paul Burgan, MD, PhD
Social Security Administration
Connie Garner, RN, MSN, EdD
US Dept of Education
Merle McPherson, MD
Maternal and Child Health Bureau
Linda Michaud, MD
American Academy of Physical Medicine and Rehabilitation
Marshalyn Yeargin-Allsopp, MD
Centers for Disease Control and Prevention
Section Liaisons
J. Daniel Cartwright, MD
Section on School Health
Chris P. Johnson, MEd, MD
Section on Children With Disabilities
Staff
Karen Smith
| |
APPENDIX I |
|---|
Helpful Resources on the Internet
| |
FOOTNOTES |
|---|
The recommendations in this statement do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.
| |
ABBREVIATIONS |
|---|
CAM, complementary and alternative medicine.
| |
REFERENCES |
|---|
|
|
|---|
Statement of reaffirmation:
This article has been cited by other articles:
![]() |
K. J. Kemper, S. Vohra, R. Walls, the Task Force on Complementary and Alternative Me, and the Provisional Section on Complementary, Holistic The Use of Complementary and Alternative Medicine in Pediatrics Pediatrics, December 1, 2008; 122(6): 1374 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Johnson Recognition of Autism Before Age 2 Years Pediatr. Rev., March 1, 2008; 29(3): 86 - 96. [Full Text] [PDF] |
||||
![]() |
S. M. Myers, C. P. Johnson, and the Council on Children With Disabilities Management of Children With Autism Spectrum Disorders Pediatrics, November 1, 2007; 120(5): 1162 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Brachlow, K. K. Ness, M. L. McPheeters, and J. G. Gurney Comparison of Indicators for a Primary Care Medical Home Between Children With Autism or Asthma and Other Special Health Care Needs: National Survey of Children's Health Arch Pediatr Adolesc Med, April 1, 2007; 161(4): 399 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kelly, K. J. Kemper, and L. D. Rosen The Role of Pediatricians Who Care for Children With Autism Arch Pediatr Adolesc Med, April 1, 2007; 161(4): 416 - 417. [Full Text] [PDF] |
||||
![]() |
A. Sawni, R. Ragothaman, R. L. Thomas, and P. Mahajan The Use of Complementary/Alternative Therapies Among Children Attending an Urban Pediatric Emergency Department Clinical Pediatrics, January 1, 2007; 46(1): 36 - 41. [Abstract] [PDF] |
||||
![]() |
J. W. Harrington, P. A. Patrick, K. S. Edwards, and D. A. Brand Parental beliefs about autism: Implications for the treating physician. Autism, September 1, 2006; 10(5): 452 - 462. [Abstract] [PDF] |
||||
![]() |
V. C.N. Wong, J.-G. Sun, and D. W.C. Yeung Pilot Study of Positron Emission Tomography (PET) Brain Glucose Metabolism to Assess the Efficacy of Tongue and Body Acupuncture in Cerebral Palsy J Child Neurol, June 1, 2006; 21(6): 455 - 462. [Abstract] [PDF] |
||||
![]() |
M. H. Cohen, K. J. Kemper, L. Stevens, D. Hashimoto, and J. Gilmour Pediatric Use of Complementary Therapies: Ethical and Policy Choices Pediatrics, October 1, 2005; 116(4): e568 - e575. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Cohen and K. J. Kemper Complementary Therapies in Pediatrics: A Legal Perspective Pediatrics, March 1, 2005; 115(3): 774 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Cooley and and Committee on Children with Disabilities Providing a Primary Care Medical Home for Children and Youth With Cerebral Palsy Pediatrics, October 1, 2004; 114(4): 1106 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L de Lemos, L. John, L. Nakashima, R. K. O'Brien, and S. C. Taylor Advising Cancer Patients on Natural Health Products--A Structured Approach Ann. Pharmacother., September 1, 2004; 38(9): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. S. Sibinga, M. C. Ottolini, A. K. Duggan, and M. H. Wilson Parent-Pediatrician Communication about Complementary and Alternative Medicine Use for Children Clinical Pediatrics, May 1, 2004; 43(4): 367 - 373. [Abstract] [PDF] |
||||
![]() |
Subcommittee on Management of Acute Otitis Media Diagnosis and Management of Acute Otitis Media Pediatrics, May 1, 2004; 113(5): 1451 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ente Prevalence of Complementary and Alternative Medicine Use in US Children Arch Pediatr Adolesc Med, March 1, 2004; 158(3): 292 - 292. [Full Text] [PDF] |
||||
![]() |
A. D. Woolf Herbal Remedies and Children: Do They Work? Are They Harmful? Pediatrics, July 1, 2003; 112(1): 240 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Pediatric Workforce Scope of Practice Issues in the Delivery of Pediatric Health Care Pediatrics, February 1, 2003; 111(2): 426 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weinstein and S. Bernstein Pink ladies: mercury poisoning in twin girls Can. Med. Assoc. J., January 21, 2003; 168(2): 201 - 201. [Full Text] [PDF] |
||||
![]() |
B. Bouch and D. S. McWaters Inadequate Internet Resources Cited Pediatrics, November 1, 2001; 108(5): 1237 - 1238. [Full Text] |
||||
![]() |
M. Shannon, S. E. Levy, and A. Sandler Chelation therapy neither safe nor effective as autism treatment AAP News, August 1, 2001; 19(2): 63 - 63. [Full Text] [PDF] |
||||
![]() |
Committee on Children With Disabilities Technical Report: The Pediatrician's Role in the Diagnosis and Management of Autistic Spectrum Disorder in Children Pediatrics, May 1, 2001; 107(5): 85e - 85. [Abstract] [Full Text] |
||||
![]() |
L. O'Keefe Weigh alternate treatment options for children with disabilities or chronic illness AAP News, March 1, 2001; 18(3): 128 - 129. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||